BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ahn KS, Kang KJ. Molecular heterogeneity in intrahepatic cholangiocarcinoma. World J Hepatol 2020; 12(12): 1148-1157 [PMID: 33442444 DOI: 10.4254/wjh.v12.i12.1148]
URL: https://www.wjgnet.com/1948-5204/full/v12/i12/1148.htm
Number Citing Articles
1
R. Sheng, B. Zheng, Y. Zhang, W. Sun, C. Yang, Y. Ding, J. Zhou, M. Zeng. “Very early” intrahepatic cholangiocarcinoma (≤ 2.0 cm): MRI manifestation and prognostic potentialClinical Radiology 2024; 79(8): 608 doi: 10.1016/j.crad.2024.05.005
2
Nurbubu T. Moldogazieva, Sergey P. Zavadskiy, Dmitry V. Astakhov, Susanna S. Sologova, Arus G. Margaryan, Anastasiya A. Safrygina, Elena A. Smolyarchuk. Differentially expressed non-coding RNAs and their regulatory networks in liver cancerHeliyon 2023; 9(9): e19223 doi: 10.1016/j.heliyon.2023.e19223
3
Alice Boilève, Marc Hilmi, Matthieu Delaye, Annemilaï Tijeras-Raballand, Cindy Neuzillet. Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?Cancers 2021; 13(11): 2708 doi: 10.3390/cancers13112708
4
Ashish Manne, Edward Woods, Allan Tsung, Arjun Mittra. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-OncologyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.768009
5
Li Ma, Xiang Li. Meeting report of the editorial board meeting for <i>World Journal of Hepatology </i>2021World Journal of Hepatology 2021; 13(2): 162-165 doi: 10.4254/wjh.v13.i2.162
6
P. Padmavathi, Anagha S. Setlur, K. Chandrashekar, Vidya Niranjan. A comprehensive in-silico computational analysis of twenty cancer exome datasets and identification of associated somatic variants reveals potential molecular markers for detection of varied cancer typesInformatics in Medicine Unlocked 2021; 26: 100762 doi: 10.1016/j.imu.2021.100762
7
Purva Gopal, Marie E. Robert, Xuchen Zhang. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision MedicineArchives of Pathology & Laboratory Medicine 2024; 148(3): 359 doi: 10.5858/arpa.2022-0537-RA
8
Masayuki Akita, Hiroaki Yanagimoto, Daisuke Tsugawa, Yoh Zen, Takumi Fukumoto. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative reviewSurgery Today 2024;  doi: 10.1007/s00595-024-02825-x
9
Francesco Vasuri, Marzia Deserti, Angelo G. Corradini, Simona Tavolari, Valeria Relli, Andrea Palloni, Giorgio Frega, Stefania Curti, Stefano Mattioli, Matteo Cescon, Antonia D’Errico, Giovanni Brandi. Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot studyScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27791-1
10
Hossein Taghizadeh, Theresa Schmalfuss, Agnieszka Maj-Hes, Josef Singer, Gerald W. Prager. Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patientsFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143825
11
Marcello Moro Queiroz, Nildevande Firmino Lima, Tiago Biachi de Castria. Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the PizzaCancers 2023; 15(7): 1970 doi: 10.3390/cancers15071970
12
Ruofan Sheng, Xiaoyong Huang, Kaipu Jin, Shanshan Gao, Mengsu Zeng, Dong Wu, Guoming Shi. Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinomaEuropean Radiology 2022; 32(8): 5156 doi: 10.1007/s00330-022-08679-6
13
Lei Zhang, Donglai Ma, Fujun Li, Gongcai Qiu, Dongsheng Sun, Zhaolin Zeng. Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU ChemoresistanceFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.871281
14
Laura Alaimo, Sara Boggio, Giovanni Catalano, Giuseppe Calderone, Edoardo Poletto, Mario De Bellis, Tommaso Campagnaro, Corrado Pedrazzani, Simone Conci, Andrea Ruzzenente. Multi-Omics Classification of Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-AnalysisCancers 2024; 16(14): 2596 doi: 10.3390/cancers16142596